Benefits (with concrete examples)
-
Ethereum (2014): From July 22 to Sept 2, 2014, Ethereum’s ICO raised about $18.3M (over 31,500 BTC). It went on to become the key smart-contract base for DeFi and NFTs.
-
Brave / BAT (2017): Raised ~$35M in under 30 seconds. By 2025 the ecosystem had grown to ~97.8M monthly active users, and the token’s use cases (ad rewards, creator payouts) were implemented.
-
Filecoin (2017 → live): $52M presale + $205M ICO. Mainnet launched Oct 15, 2020; by 2025 Q2 the network reported ~1,100 PiB of active stored data—evidence of real demand.
-
Chainlink (2017): Raised $32M. Decentralized oracles supplying off-chain data are now widely integrated across projects.
Takeaway: When capital → product → real usage lined up (Ethereum/Brave/Filecoin/Chainlink), the ICO served as an effective initial accelerator.
Harms (where problems surfaced)
-
BitConnect (2017–2018): High-yield “program” deemed a Ponzi. U.S. DOJ cited ~$2B scale; courts ordered $17M+ in restitution in 2023.
-
Telegram / GRAM (2018–2020): Raised ~$1.7B, but the SEC argued it was an unregistered securities offering. June 26, 2020 settlement: $1.2B returned + $18.5M penalty; token distribution aborted.
-
EOS / Block.one (2017–2018): Raised ~$4B; in 2019 the SEC settled for $24M over unregistered securities issues—showing that even record-size raises must pass regulatory muster.
-
Tezos (2017): Raised ~$232M, then faced governance disputes and class actions. Settled in 2020 for $25M (without a court ruling on illegality).
-
Centra Tech (2017): Celebrity-promoted ICO found to be fraudulent. Co-founders convicted; promoters were also charged for undisclosed paid touting.
-
China’s blanket ban (2017/9/4): PBoC and other regulators banned ICOs and ordered funds returned—a stark example of jurisdictions where ICOs are fundamentally disallowed.
Takeaway: Fraud, unregistered sales, flawed tokenomics/governance, and prohibitive local rules can quickly trigger distribution halts, repayments, and sanctions.
Practical implications (ultra-brief)
-
For investors: Check the jurisdiction and applicable law, the white paper’s use of proceeds & lockups, presence of third-party vetting (e.g., IEO), custody/transfer limits, and governance/conflicts. Treat ICO exposure as high risk; use small, diversified positions.
-
For issuers: Assume existing regimes apply (e.g., EU MiCA, U.S. Howey analysis). Favor registered/qualified paths like IEO/STO and design issuance within the regulatory perimeter.
Comments
Post a Comment